Aarkstore announce a new report "Tyrihans, Norway, Commercial Asset Valuation and Forecast to 2024 " through its vast collection of market research report.Tyrihans, Norway, Commercial Asset Valuation and Forecast to 2024 - Tyrihans is located in Haltenbank area of the Norwegian Sea in the Norway. Tyrihans is an oil and gas field which covers total area of 117.62 square kilometers. StatoilHydro is the operator of the field since its discovery in...more
Aarkstore announce a new report "Valhall, Norway, Commercial Asset Valuation and Forecast to 2035 " through its vast collection of market research report.Valhall, Norway, Commercial Asset Valuation and Forecast to 2035 - Valhall is located in blocks 2/11 and 2/8 in the southern part of the Norwegian North Sea close to the UK and Danish borders. Valhall is oil and gas field covering a total area of 104.96 Squarekilometer. Valhall was discovered...more
The pricing landscape has changed dramatically over the past decade. In the 1990s and even a few years ago, pricing was almost an afterthought pricing plans were formed and carried out during ramp-up to product launch; there was less regulatory scrutiny; the concept of health outcomes analysis was still taking shape, and any pharmacoeconomic data that companies were able to provide was better than none.Today, however, strategic pricing is more important than ever before. Pharmaceutical and biotechnology companies' pricing teams contend with unrelenting pressures. They must manage increased scrutiny from different sides government agencies, the media and the public over pharmaceutical pricing, while meeting multiple stakeholders' needs: third-party payers, physicians and patients. Adding to the complexity are ever-rising clinical development costs and shrinking pipelines in a constantly changing, global marketplace.As a result of these challenges, pharmaceutical pricing has become payer-driven and value-based. But life sciences companies are also recognizing the vital importance of strategic pricing. Rather than coming at the tail end of a drug's development, pricing planning is...more
Pharmaceutical competitive intelligence (CI) helps drive decision-making processes across an organization. As a forward-thinking, proactive support function, CI influences business development and brand management, among other areas. CI identifies market risks as well as business growth opportunities.Recent years have seen CI groups on the upswing....more
Through a comparative analysis on the development of pigments mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the pigments mfg. industry in China, a list of top 20 enterprises in the sector as well as the comparison on investment environment in top 10...more
Through a comparative analysis on the development of dyestuff mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the dyestuff mfg. industry in China, a list of top 20 enterprises in the sector as well as the comparison on investment environment in top 10 hot regions. In addition, the report truly reflects the position of foreign enterprises in dyestuff mfg. industry across China based on a comprehensive comparison of operating conditions among different enterprise types.This report is based on Chinese industry classification (Industrial Classification For National Economic Activities, GB/T 4754-2002).Additionally, by original creation of ZEEFER Industry Distribution Index, the report directly shows the difference in various regions of Mainland China in terms of dyestuff mfg. industry, providing an important reference for investors selection of target regions to make investment.What will you get from this report? To get a comprehensive picture on distribution of and difference in performance in regions of Mainland China in terms of the dyestuff mfg. industry; To figure out the hot regions in...more
Through a comparative analysis on the development of sealing filler mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the sealing filler mfg. industry in...more
Through a comparative analysis on the development of basic plastics & synthetic resin industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the basic plastics &...more
Through a comparative analysis on the development of synthetic rubber industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the synthetic rubber industry in China, a...more
Through a comparative analysis on the development of synthon single (polymerization) mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the synthon single...more
Through a comparative analysis on the development of chemical reagent & catalysts mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the chemical reagent &...more
The evolving IPTV and VAS model for the telecoms operatorIndustry convergence is increasing the pressure on telcos to refine the role they wish to play in content markets. Historically, telcos have participated in two of these content markets. Mobile...more